Primary study · included by 1 review

An Innovative Strategy for Oral Biofilm Control in Early Childhood Based on a Resveratrol-Cyclodextrin Nanotechnology Approach.

Berta 2021 · Berta Giovanni Nicolao, Romano Federica, Vallone Roberta, et al. · Materials (Basel, Switzerland) · 2021

Included by

Resveratrol as an Adjunct Therapy in Periodontal Disease: A Systematic Review and Meta-Analysis.
Non-Cochrane · intervention · 2026 · cited as Berta 2021 · Table 3; reference 40
Outcome this study informsPooled effectEvidenceCertainty
Bleeding index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo
MD -8.11 [-9.57, -6.64]3 studiesGRADE not reported
Bleeding index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo
MD -8.95 [-10.47, -7.43]3 studiesGRADE not reported
Bleeding index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo
MD -7.72 [-9.13, -6.32]4 studiesGRADE not reported
Bleeding index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo
MD -6.79 [-9.06, -4.51]3 studiesGRADE not reported
Bleeding index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo
MD -6.50 [-8.02, -4.97]3 studiesGRADE not reported
Bleeding index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo · Post-treatment time point most comparable across trials
MD -6.82 [-12.12, -1.53]4 studies · 187 participantsLow
Plaque index (%)
Adjunctive resveratrol (oral, gel, spray, mouthwash) with non-surgical periodontal therapy or plaque control vs Non-surgical periodontal therapy or plaque control alone, or placebo · Post-treatment time point most comparable across trials
MD -12.61 [-16.41, -8.80]3 studies · 143 participantsLow

1 including review in total.